LENZ Therapeutics, Inc.

Healthcare

NASDAQ:LENZ · NASDAQ Global Select

Market Cap $198.79M Beta 1.47 P/E (TTM) -1.7

$6.15 -6.62%

-$0.42 today

52W Low $5.85High $50.40

Vol 1.12M · Avg 0.89M

EPS (TTM) -$3.48Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-79.82%

Period High

$49.05

Period Low

$6.15

Latest

$6.15

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Nanobiotix S.A.

NASDAQ:NBTX

$1.79B

Tyra Biosciences, Inc.

NASDAQ:TYRA

$1.68B

GH Research PLC

NASDAQ:GHRS

$1.55B

Savara Inc.

NASDAQ:SVRA

$1.11B

ARS Pharmaceuticals, Inc.

NASDAQ:SPRY

$959.27M

Arbutus Biopharma Corporation

NASDAQ:ABUS

$896.82M

Geron Corporation

NASDAQ:GERN

$814.73M

Maravai LifeSciences Holdings, Inc.

NASDAQ:MRVI

$747.97M

Prime Medicine, Inc.

NASDAQ:PRME

$575.27M

Rezolute, Inc.

NASDAQ:RZLT

$489.65M

What is the latest LENZ filing?

The latest filing shown is 4 dated Jun 15, 2026.

How many recent filings does LENZ have?

Intrinsic Alpha currently shows 20 recent filings for LENZ.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.